Skip to main content
Filing year 2023

THE OVARIAN CANCER RESEARCH FUND INC

New York, New York·EIN 13-3806788·NTEE T70Z · Philanthropy, Voluntarism & Grantmaking Foundations·3
Total revenue
$13.4M
Total assets
$39.2M
Total expenses
$0
Reported officers
26
Mission

OVARIAN CANCER RESEARCH ALLIANCE (OCRA) IS COMMITTED TO PREVENTING, DEVELOPING BETTER TREATMENTS FOR AND ULTIMATELY CURING OVARIAN AND RELATED GYNECOLOGIC CANCERS THROUGH INNOVATIVE RESEARCH, RAISING AWARENESS AND ENSURING THE BEST CARE POSSIBLE THROUGH ADVOCACY AND SUPPORT FOR PATIENTS AND FAMILIES.

Executive compensation, broken down

Form 990 · Schedule J · 7 reported individuals · Filing year 2023

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
$346k
Chief Development Officer
$233k
Chief Financial Officer
$230k
Chief Program Officer
highest compensated employee
$220k
Vp - Support & Education
vice president
$178k
Vp - Philanthropic Partner
vice president
$154k
Vp - Policy
vice president
$144k

Plus 19 unpaid individuals.

Browse compensation in Philanthropy, Voluntarism & Grantmaking

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.